NCT01130077 - A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions

Newly Diagnosed Pediatric Pontine GliomaNewly Diagnosed Pediatric High Grade GliomaRecurrent Pediatric High Grade GliomaRecurrent Pediatric Low Grade Glioma

Interventions

BIOLOGICAL

HLA-A2 restricted glioma antigen peptides vaccine

Vaccine given every 3 weeks

BIOLOGICAL

Poly-ICLC

Vaccine given every 3 weeks

Trial Locations (1)

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh